Bemnifosbuvir hemisulfate
Bemnifosbuvir hemisulfate (AT-527) is a direct-acting antiviral nucleotide prodrug that potently inhibits hepatitis C virus (HCV) replication. It has demonstrated antiviral activity in both in vitro assays and in vivo clinical studies, making it a valuable tool for HCV research.
Product Specifications
CAS Number
2241337-84-6
Product Name Alternative
Bemnifosbuvir, Bemnifosbuvir hemisulfate, Bemnifosbuvir Hemisulfate, antiviral, AT 527, AT527, AT-527, HCVProtease, HCV, HCV Protease, Hepatitis C virus, guanosine, Inhibitor, inhibit, pangenotypic, nucleotide, phosphoramidate, SARS coronavirus, SARSCoV, SARS-CoV, SARS-CoV-2
Field of Research
Infectious Disease & Virology, Protein Biochemistry
Purity
99.74% (May vary between batches)
Solubility
DMSO:170 mg/mL (134.8 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (3.96 mM)
Smiles
C[C@@H] (C (OC (C) C) =O) N[P@@] (OC1=CC=CC=C1) (OC[C@H]2O[C@@H] (N3C=NC4=C (NC) N=C (N) N=C34) [C@] (C) (F) [C@@H]2O) =O.C[C@@H] (C (OC (C) C) =O) N[P@@] (OC5=CC=CC=C5) (OC[C@H]6O[C@@H] (N7C=NC8=C (NC) N=C (N) N=C78) [C@] (C) (F) [C@@H]6O) =O.O=S (O) (O) =O
Molecular Formula
C48H68F2N14O18P2S
Molecular Weight
1261.15
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog